Given the opposing roles of cannabinoid receptor and TRPV1 activation in regulating anxiety, novel drugs combining cannabinoid receptor agonist and TRPV1 antagonist properties may have synergistic anxiolytic effects [116]. Here, TRPV1 is linked to Anxiety.